并购提速!复星、佐力、诺和诺德等多家药企年底"精准补位"

中国粉体网
Dec 16, 2025

中国粉体网讯2025年底药企收购频繁,“补短板、强协同”趋势显著。在行业竞争加剧背景下,并购成企业追赶技术、弥补短板、构建壁垒的“捷径”。12月15日,复星医药宣布,控股子公司复星医药产业与绿谷医药及其现有相关股东共同签订相关投资协议,拟出资约14.12亿元控股收购绿谷医药。本次收购完成后,绿谷医药将成为复星医药控股子公司,其核心药品甘露特钠胶囊(商品名“九期一”)也将纳入复星医药创新药品管线,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10